65316-39-4Relevant academic research and scientific papers
Development of N6-(Heteroarylcarbonyl) adenines as BRD4 inhibitors
Amemiya, Seika,Yamaguchi, Takao,Hashimoto, Yuichi,Noguchi-Yachide, Tomomi
, p. 1107 - 1114 (2017/06/13)
N6-(Heteroarylcarbonyl)adenines were synthesized as candidate BRD4 inhibitors, and their structure-activity relationships were investigated. Among the synthesized compounds, N6-[(3-methoxythiophen-2-yl)carbonyl]adenine (15) showed th
COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE
-
Page/Page column 129, (2015/09/22)
The present disclosure is directed, in part, to compounds, or pharmaceutically acceptable salts thereof, for the treatment and/or prevention of neurodegenerative disease and/or mitchonodrial disease including Parkinson's disease and Leigh's disease.
